메뉴 건너뛰기
Journal of Thoracic Oncology
Volumn 10, Issue 5, 2015, Pages e33-e34
MET-mutated NSCLC with major response to crizotinib
Author keywords

[No Author keywords available]
Indexed keywords

CARBOPLATIN; CRIZOTINIB; FLUORODEOXYGLUCOSE F 18; GEMCITABINE; PACLITAXEL; SCATTER FACTOR RECEPTOR; ANTINEOPLASTIC AGENT; MET PROTEIN, HUMAN; PYRAZOLE DERIVATIVE; PYRIDINE DERIVATIVE;
EID: 84938227821     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000491     Document Type: Letter
Times cited : (56)
References (5)
  • 1
    • 79955458487 scopus 로고    scopus 로고
    • Activity of crizotinib (pf02341066), a dual mesenchymal-epithelial transition (met) and anaplastic lymphoma kinase (alk) inhibitor, in a non-small cell lung cancer patient with de novo met amplification
    • Ou SH, Kwak EL, Siwak-Tapp C, Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification. J Thorac Oncol 2011 6 942 946
    • (2011) J Thorac Oncol , vol.6 , pp. 942-946
    • Ou, S.H.1    Kwak, E.L.2    Siwak-Tapp, C.3
  • 2
    • 34249912683 scopus 로고    scopus 로고
    • C-Met activation in lung adenocarcinoma tissues: An immunohistochemical analysis
    • Nakamura Y, Niki T, Goto A, c-Met activation in lung adenocarcinoma tissues: an immunohistochemical analysis. Cancer Sci 2007 98 1006 1013
    • (2007) Cancer Sci , vol.98 , pp. 1006-1013
    • Nakamura, Y.1    Niki, T.2    Goto, A.3
  • 3
    • 55449116539 scopus 로고    scopus 로고
    • Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer
    • Okuda K, Sasaki H, Yukiue H, Yano M, Fujii Y., Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer. Cancer Sci 2008 99 2280 2285
    • (2008) Cancer Sci , vol.99 , pp. 2280-2285
    • Okuda, K.1    Sasaki, H.2    Yukiue, H.3    Yano, M.4    Fujii, Y.5
  • 4
    • 61549138135 scopus 로고    scopus 로고
    • Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers
    • Onozato R, Kosaka T, Kuwano H, Sekido Y, Yatabe Y, Mitsudomi T., Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers. J Thorac Oncol 2009 4 5 11
    • (2009) J Thorac Oncol , vol.4 , pp. 5-11
    • Onozato, R.1    Kosaka, T.2    Kuwano, H.3    Sekido, Y.4    Yatabe, Y.5    Mitsudomi, T.6
  • 5
    • 84902811306 scopus 로고    scopus 로고
    • Efficacy and safety of crizotinib in patients with advanced c-MET-amplified non-small cell lung cancer (NSCLC
    • suppl; abstr 8001
    • Camidge DR, Ou SI, Shapiro G, Efficacy and safety of crizotinib in patients with advanced c-MET-amplified non-small cell lung cancer (NSCLC). J Clin Oncol 2014 32 suppl; abstr 8001 5s
    • (2014) J Clin Oncol , vol.32 , pp. 5s
    • Camidge, D.R.1    Ou, S.I.2    Shapiro, G.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.